{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:45:23Z","timestamp":1759340723049,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B2005081"],"award-info":[{"award-number":["2017R1A2B2005081"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyloid-\u03b2 (A\u03b2) and cerebral small vessel disease (CSVD) commonly coexist. They can occur independently by chance, or may interact with each other. We aimed to determine whether the distribution of A\u03b2 in subcortical vascular cognitive impairments (SVCI) patients can be classified by the underlying pathobiologies. A total of 45 <jats:sup><jats:bold>11<\/jats:bold><\/jats:sup>C-Pittsburgh compound B PET positive (PiB(+)) SVCI patients were included in this study. They were classified using a new cluster analysis method which adopted the Louvain method, which finds optimal decomposition of the participants based on similarity of relative A\u03b2 deposition pattern. We measured atherosclerotic cerebral small vessel disease (CSVD) markers and cerebral amyloid angiopathy (CAA) markers. Forty-five PiB(+) SVCI patients were classified into two groups: 17 patients with the characteristic Alzheimer\u2019s disease like A\u03b2 uptake with sparing of occipital region (OccSp) and 28 patients with occipital predominant A\u03b2 uptake (OccP). Compared to OccSp group, OccP group had more postive association of atherosclerotic CSVD score (<jats:italic>p<\/jats:italic> for interaction\u2009=\u20090.044), but not CAA score with occipital\/global ratio of PiB uptake. Our findings suggested that A\u03b2 positive SVCI patients might consist of heterogeneous groups with combined CSVD and A\u03b2 resulting from various pathobiologies. Furthermore, atherosclerotic CSVD might explain increased occipital A\u03b2 uptakes.<\/jats:p>","DOI":"10.1038\/s41598-018-34032-3","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T10:39:54Z","timestamp":1540550394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-1274","authenticated-orcid":false,"given":"Hyemin","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Yun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Kyoung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin San","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-5420","authenticated-orcid":false,"given":"Samuel N.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Kyung","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"34032_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","volume":"349","author":"A Hofman","year":"1997","unstructured":"Hofman, A. et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer\u2019s disease in the Rotterdam Study. Lancet 349, 151\u2013154 (1997).","journal-title":"Lancet"},{"key":"34032_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jalz.2010.08.228","volume":"7","author":"AE Roher","year":"2011","unstructured":"Roher, A. E. et al. Intracranial atherosclerosis as a contributing factor to Alzheimer\u2019s diseasedementia. Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association 7, 436\u2013444 (2011).","journal-title":"Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association"},{"key":"34032_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","volume":"59","author":"NS Shah","year":"2012","unstructured":"Shah, N. S. et al. Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension 59, 780\u2013786 (2012).","journal-title":"Hypertension"},{"key":"34032_CR4","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal, D. R., Ghebremedhin, E., Orantes, M. & Wiestler, O. D. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62, 1287\u20131301 (2003).","journal-title":"J Neuropathol Exp Neurol"},{"key":"34032_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00401-002-0634-5","volume":"105","author":"KA Jellinger","year":"2003","unstructured":"Jellinger, K. A. & Attems, J. Incidence of cerebrovascular lesions in Alzheimer\u2019s disease: a postmortem study. Acta neuropathologica 105, 14\u201317 (2003).","journal-title":"Acta neuropathologica"},{"key":"34032_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-010-0652-7","volume":"119","author":"LT Grinberg","year":"2010","unstructured":"Grinberg, L. T. & Thal, D. R. Vascular pathology in the aged human brain. Acta neuropathologica 119, 277\u2013290 (2010).","journal-title":"Acta neuropathologica"},{"key":"34032_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0b013e318221acee","volume":"77","author":"JH Lee","year":"2011","unstructured":"Lee, J. H. et al. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 77, 18\u201325 (2011).","journal-title":"Neurology"},{"key":"34032_CR8","first-page":"243","volume":"134","author":"K Ogomori","year":"1989","unstructured":"Ogomori, K. et al. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer\u2019s disease. Am J Pathol 134, 243\u2013251 (1989).","journal-title":"Am J Pathol"},{"key":"34032_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/brain\/aws327","volume":"136","author":"M Lehmann","year":"2013","unstructured":"Lehmann, M. et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer\u2019s disease. Brain: a journal of neurology 136, 844\u2013858 (2013).","journal-title":"Brain: a journal of neurology"},{"key":"34032_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000139788","volume":"128","author":"S Pantelakis","year":"1954","unstructured":"Pantelakis, S. A particular type of senile angiopathy of the central nervous system: congophilic angiopathy, topography and frequency. Monatsschr Psychiatr Neurol 128, 219\u2013256 (1954).","journal-title":"Monatsschr Psychiatr Neurol"},{"key":"34032_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","volume":"37","author":"J Attems","year":"2011","unstructured":"Attems, J., Jellinger, K., Thal, D. & Van Nostrand, W. Review: sporadic cerebral amyloid angiopathy. Neuropathology and applied neurobiology 37, 75\u201393 (2011).","journal-title":"Neuropathology and applied neurobiology"},{"key":"34032_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ana.21164","volume":"62","author":"KA Johnson","year":"2007","unstructured":"Johnson, K. A. et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Annals of neurology 62, 229\u2013234 (2007).","journal-title":"Annals of neurology"},{"key":"34032_CR13","doi-asserted-by":"crossref","unstructured":"Noh, Y. et al. The Role of Cerebrovascular Disease in Amyloid Deposition. Journal of Alzheimer\u2019s disease: JAD (2016).","DOI":"10.3233\/JAD-150832"},{"key":"34032_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3233\/JAD-130461","volume":"40","author":"Y Noh","year":"2014","unstructured":"Noh, Y. et al. White Matter Hyperintensities are associated with Amyloid Burden in APOE4 Non-Carriers. Journal of Alzheimer\u2019s disease: JAD 40, 877\u2013886 (2014).","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"34032_CR15","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1016\/j.neurobiolaging.2013.05.009","volume":"34","author":"HJ Kim","year":"2013","unstructured":"Kim, H. J. et al. Effects of APOE epsilon4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment. Neurobiology of aging 34, 2482\u20132487 (2013).","journal-title":"Neurobiology of aging"},{"key":"34032_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0031-1277990","volume":"31","author":"SK Feske","year":"2011","unstructured":"Feske, S. K. Posterior reversible encephalopathy syndrome: a review. Seminars in neurology 31, 202\u2013215 (2011).","journal-title":"Seminars in neurology"},{"key":"34032_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10014-016-0255-7","volume":"33","author":"M Ueno","year":"2016","unstructured":"Ueno, M. et al. Blood\u2013brain barrier and blood\u2013cerebrospinal fluid barrier in normal and pathological conditions. Brain tumor pathology 33, 89\u201396 (2016).","journal-title":"Brain tumor pathology"},{"key":"34032_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nature reviews. Neuroscience 12, 723\u2013738 (2011).","journal-title":"Nature reviews. Neuroscience"},{"key":"34032_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell, R. D. & Zlokovic, B. V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118, 103\u2013113 (2009).","journal-title":"Acta Neuropathol"},{"key":"34032_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane, R. et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9, 907\u2013913 (2003).","journal-title":"Nat Med"},{"key":"34032_CR21","first-page":"463","volume":"10","author":"M Ujiie","year":"2003","unstructured":"Ujiie, M., Dickstein, D. L., Carlow, D. A. & Jefferies, W. A. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463\u2013470 (2003).","journal-title":"Microcirculation"},{"key":"34032_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","volume":"197","author":"BV Zlokovic","year":"1993","unstructured":"Zlokovic, B. V. et al. Blood-brain barrier transport of circulating Alzheimer\u2019s amyloid beta. Biochem Biophys Res Commun 197, 1034\u20131040 (1993).","journal-title":"Biochem Biophys Res Commun"},{"key":"34032_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neurobiolaging.2007.06.005","volume":"30","author":"MT Gentile","year":"2009","unstructured":"Gentile, M. T. et al. Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiology of aging 30, 222\u2013228 (2009).","journal-title":"Neurobiology of aging"},{"key":"34032_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1161\/01.STR.27.3.408","volume":"27","author":"SE Starkstein","year":"1996","unstructured":"Starkstein, S. E. et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer\u2019s disease. Stroke 27, 408\u2013414 (1996).","journal-title":"Stroke"},{"key":"34032_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0197-4580(01)00319-0","volume":"23","author":"KG Pugh","year":"2002","unstructured":"Pugh, K. G. & Lipsitz, L. A. The microvascular frontal-subcortical syndrome of aging. Neurobiology of aging 23, 421\u2013431 (2002).","journal-title":"Neurobiology of aging"},{"key":"34032_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. Journal of internal medicine 256, 183\u2013194 (2004).","journal-title":"Journal of internal medicine"},{"key":"34032_CR27","unstructured":"Kang, Y. & Na, D. L. Seoul Neuropsychological Screening Battery (SNSB). (Human Brain Research & Consulting Co., 2003)."},{"key":"34032_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"HJ Ahn","year":"2010","unstructured":"Ahn, H. J. et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 25, 1071\u20131076 (2010).","journal-title":"J Korean Med Sci"},{"key":"34032_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1176\/appi.neuropsych.16.1.83","volume":"16","author":"P Sachdev","year":"2004","unstructured":"Sachdev, P., Wen, W., Shnier, R. & Brodaty, H. Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. The Journal of neuropsychiatry and clinical neurosciences 16, 83\u201392 (2004).","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"key":"34032_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw, J. M. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. Neurology 12, 822\u2013838 (2013).","journal-title":"The Lancet. Neurology"},{"key":"34032_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3174\/ajnr.A0783","volume":"29","author":"J Linn","year":"2008","unstructured":"Linn, J. et al. Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 29, 184\u2013186 (2008).","journal-title":"AJNR Am J Neuroradiol"},{"key":"34032_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","volume":"41","author":"FN Doubal","year":"2010","unstructured":"Doubal, F. N., MacLullich, A. M., Ferguson, K. J., Dennis, M. S. & Wardlaw, J. M. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 41, 450\u2013454 (2010).","journal-title":"Stroke"},{"key":"34032_CR33","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/jnnp.2003.030858","volume":"75","author":"AM Maclullich","year":"2004","unstructured":"Maclullich, A. M. et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. Journal of neurology, neurosurgery, and psychiatry 75, 1519\u20131523 (2004).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"34032_CR34","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1136\/jnnp.2006.089292","volume":"77","author":"CA Jackson","year":"2006","unstructured":"Jackson, C. A. & Sudlow, C. L. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? Journal of Neurology, Neurosurgery & Psychiatry 77, 1244\u20131252 (2006).","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"34032_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg, S. M. et al. Cerebral microbleeds: a guide to detection and interpretation. The Lancet Neurology 8, 165\u2013174 (2009).","journal-title":"The Lancet Neurology"},{"key":"34032_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/WNL.0000000000003746","volume":"88","author":"A Charidimou","year":"2017","unstructured":"Charidimou, A. et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 88, 1157\u20131164 (2017).","journal-title":"Neurology"},{"key":"34032_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology 9, 689\u2013701 (2010).","journal-title":"The Lancet Neurology"},{"key":"34032_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn, J. et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74, 1346\u20131350 (2010).","journal-title":"Neurology"},{"key":"34032_CR39","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals, J., Makin, S. D., Doubal, F. N., Dennis, M. S. & Wardlaw, J. M. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 83, 1228\u20131234 (2014).","journal-title":"Neurology"},{"key":"34032_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaneurol.2016.0832","volume":"73","author":"A Charidimou","year":"2016","unstructured":"Charidimou, A. et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. JAMA neurology 73, 994\u20131001 (2016).","journal-title":"JAMA neurology"},{"key":"34032_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer, N. et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain. NeuroImage 15, 273\u2013289 (2002).","journal-title":"NeuroImage"},{"key":"34032_CR42","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2967\/jnumed.114.146027","volume":"56","author":"CH Lyoo","year":"2015","unstructured":"Lyoo, C. H. et al. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein. J Nucl Med 56, 701\u2013706 (2015).","journal-title":"J Nucl Med"},{"key":"34032_CR43","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe, C. C. et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of aging 31, 1275\u20131283 (2010).","journal-title":"Neurobiology of aging"},{"key":"34032_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/00007890-199103000-00024","volume":"51","author":"N Bonnefoy-Berard","year":"1991","unstructured":"Bonnefoy-Berard, N., Vincent, C. & Revillard, J. P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51, 669\u2013673 (1991).","journal-title":"Transplantation"},{"key":"34032_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awm336","volume":"131","author":"CR Jack Jr.","year":"2008","unstructured":"Jack, C. R. Jr. et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment. Brain: a journal of neurology 131, 665\u2013680 (2008).","journal-title":"Brain: a journal of neurology"},{"key":"34032_CR46","doi-asserted-by":"publisher","first-page":"43270","DOI":"10.1038\/srep43270","volume":"7","author":"JY Park","year":"2017","unstructured":"Park, J. Y. et al. Robust Identification of Alzheimer\u2019s Disease subtypes based on cortical atrophy patterns. Sci Rep-Uk 7, 43270 (2017).","journal-title":"Sci Rep-Uk"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34032-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:12:07Z","timestamp":1671621127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34032-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34032"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34032-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"29 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16178"}}